Global /Japan /Healthcare /Drug Manufacturers - Specialty & Generic /4571

Nano Holdings, Inc.

4571

• TSE: 4571 • Delayed

138JPY -1.4%

0.8606 USD

As of 13 June 2026, Nano Holdings, Inc. has a market cap of $70.3M USD, ranking #28079 globally and #2532 in Japan. It ranks #2536 in the Healthcare sector, and #137 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

28079

Country Rank

2532

Sector Rank

2536

Industry Rank

137

Key Stats

Market Cap

$70.3MUSD

11.25B JPY

Enterprise Value

$52.92MUSD

8.49B JPY

Revenue (TTM)

$968.26KUSD

155.0M JPY

Net Income (TTM)

-$5.54MUSD

-887.0M JPY

PS Ratio

72.6

PB Ratio

4.2

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Shiro Akinaga open_in_new

Employees

Founded

1996

Website

nanomrna.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.4%	-3.4%	-14%	-0.7%	-13%	-1.4%	6.9%	-35%	-54%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	4571 Nano Mrna Co Ltd ISIN: JP3651120002 Shares Out.: Shares Outstanding: 83.189M¹ Shares Float: 77.792M² TV: TradingView: TSE: 4571 SA: Stock Analysis: TYO: 4571 YF: Yahoo Finance: 4571.T GF: Google Finance: TYO: 4571 BA: Barron's: 4571 MS: Morningstar: XTKS: 4571	138 JPY	TV: TradingView: TSE: 4571 SA: Stock Analysis: TYO: 4571 YF: Yahoo Finance: 4571.T GF: Google Finance: TYO: 4571 BA: Barron's: 4571 MS: Morningstar: XTKS: 4571

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nano Holdings, Inc.

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company’s pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Japan)

Name	Market Cap (USD) diff.	PE	Country
Hisamitsu Pharmaceutical Co., Inc. TSE: 4530	$2.66B 425.23B JPY 4K%	22.5	Japan
Torii Pharmaceutical Co., Ltd. TSE: 4551	$1.11B 178.26B JPY 1K%	33.0	Japan
Euglena Co., Ltd. TSE: 2931	$350.57M 56.12B JPY 399%	-	Japan
Yomeishu Seizo Co.,Ltd. TSE: 2540	$347.7M 55.66B JPY 395%	74.9	Japan
AnGes, Inc. TSE: 4563	$128.51M 20.57B JPY 83%	-	Japan
Astena Holdings Co., Ltd. TSE: 8095	$121.54M 19.46B JPY 73%	8.6	Japan

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 52K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 42K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 22K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 16K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 16K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 13K%	80.6	China

chevron_leftBack